CLINICAL_TRIALS
trial_result
· 2023-11-07
Clinical Trial Update: Tiotropium/Salmeterol Inhalation Powder in COPD [Phase 3]
Summary
Phase 3 trial update for tiotropium/salmeterol inhalation powder in chronic obstructive pulmonary disease has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: TERMINATED